Language

English

Publication Date

4-1-2025

Journal

Cleveland Clinic Journal of Medicine

DOI

10.3949/ccjm.92a.24098

PMID

40169223

Abstract

Whether subclinical hypothyroidism should be treated in elderly patients (≥ 65 years) is controversial. The authors argue for a personalized, wait-and-see approach rather than universal treatment, pointing out that randomized clinical trials have not shown that levothyroxine treatment makes any difference in terms of hard clinical end points, quality of life, or hypothyroid symptom relief in elderly patients with this condition.

Keywords

Humans, Hypothyroidism, Aged, Thyroxine, Quality of Life, Aged, 80 and over, Female

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.